2m 2m 2m 2m 2m 2m 2m
FORTE BIOSCIENC (FBRX)
NASDAQ
$76.94+$0.02 (+0.02%)
Price as of Aug 24, 2026 10:22 AM EDT- $1.6BMarket Cap
- 572.97%1-Year Change
- BiotechnologyIndustry
FORTE BIOSCIENC (FBRX)
$76.94+$0.02 (+0.02%)
FBRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $76.92 | ||
Change | +$0.03 (+0.04%) | ||
Open | $76.94 | ||
High | $76.95 | ||
Low | $76.89 | ||
Previous Close | $76.89 | ||
Volume | 2,012,128 | ||
30-Day Average Volume | 2,467,721 | ||
1-Week Change | 0.12% | ||
1-Month Change | 51.63% | ||
1-Year Change | 572.97% | ||
3-Year Change | 270.70% | ||
5-Year Change | -88.62% | ||
Fundamentals | |||
Shares Outstanding | 21.2M | ||
Total Assets | $205.7M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | -$50,000.00 | ||
Net Income | -$23.3M | ||
Free Cash Flow | -$22.7M | ||
EBIT | -$23.1M | ||
EBITDA | -$23.1M | ||
Net Working Capital | $182.8M | ||
EPS | -$0.97 | ||
Enterprise Value/EBITDA | -68 | ||
Enterprise Value/Revenue | -31,666 | ||
P/B | 9 | ||
P/E | -79 | ||
PEG | -4 | ||
Price/Free Cash Flow | -72 | ||
Price/Operating Cash Flow | -72 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/28/2024 | ||
Earnings & Revenue